移植免疫學 的英文怎麼說

中文拼音 [yízhímiǎnyìxué]
移植免疫學 英文
transplantation immunology
  • 移 : Ⅰ動詞1. （移動） move; remove; shift 2. （改變; 變動） change; alter Ⅱ名詞（姓氏） a surname
  • 植 : Ⅰ動詞1. （栽種） plant; grow; cultivate 2. （樹立） establish; set up Ⅱ名詞（姓氏） a surname
  • 免 : Ⅰ動詞1 （去掉;除掉） dismiss; relieve; remove 2 （避免） avoid; escape; avert 3 （免去） excuse s...
  • 疫 : 名詞（瘟疫） epidemic disease; pestilence
  • 學 : Ⅰ動詞1 （學習） study; learn 2 （模仿） imitate; mimic Ⅱ名詞1 （學問） learning; knowledge 2 （學...
  • 移植 : 1. [農業] （移苗） transplant 2. [醫學] （機體移植） transplanting; grafting; removal
  1. Transplantation has been developed to an effctive strategy for treatment of end stage diseases of multiple organs since 1950 ' s. despite success of current immunosuppressive drugs, transplantation immunologists and surgeons are still seeking to achieve tolerance to allograft. there are several different mechanisms such as clonal deletion, anergy, neglect, immuno regulation. which maintain tolerance to self - antigen. some strategies, derived from these mechanisms has been proved to be encouraged in suppression of allograft rejection

    二十世紀五十年代以來，器官移植的進展使同種異體器官移植成為治療多種器官終末期疾病的有效手段。盡管目前免疫抑制方案非常有效，但免疫耐受仍是移植免疫學家和外科醫生關注的課題。有多個機制使免疫系統對自身抗原保持耐受，如：克隆清除、忽略、失能、免疫調節。
  2. The rse was then grafted to the dorsum of scid mice to evaluate its biocompatibility by histologic and immunohistochemistry analysis

    將人包皮的表皮細胞和真皮的成纖維細胞復合到上述材料上培養7天後，移植到裸鼠背部，進行生物相容性、組織學和免疫組織化學的分析。
  3. Immunological research of osteoblast allotransplantation

    同種異體成骨細胞移植的免疫學研究
  4. 2. rat orthotopic liver trarlsplantation was performed in the strong rejecter combination of bn ( rtl " ) to lew ( rtl l ). this al1ogenic rejection model was stable and the survival time without immunosuppression agents was less than three weeks ( the average survival time was l 6. 6 i 2. 5 days, n = 5 )

    建立了大鼠bn （ rt1 ~ n ） lew （ rt1 ~ l ）原位肝移植同種異體排斥模型，該模博士學位論義基因轉移hu la個ig誘導大鼠移植肝免疫耐受的實驗研究中文摘要型排斥反應時間較為恆定，在不應用免疫抑制劑的情況下，生存期3周（平均生存時問人66士2
  5. The alternative is to use potent immunosuppressants, drugs that are used to prevent rejection after organs transplantation or as chemotherapy to treat cancer

    免疫系統抑制劑，一般是在器官移植手術后，用於壓制排斥反應，或是用作化學治療劑去醫治癌癥病人。
  6. Basic science research plays an equally important role in the understanding of disease mechanisms, and the faculty emphasizes the integration of basic science research and clinical research, such as in the areas of transplantation immunology, molecular and cellular biology in various cancers, developmental biology of paediatric surgical diseases, and common childhood diseases

    基礎科學研究對了解疾病同樣重要。醫學院非常著重基礎科學研究及臨床研究的結合，例如在移植免疫學、有關各種癌癥的分子及細胞生物學、小兒外科疾病的發育生物學及一般兒科疾病等范疇。
  7. Recent developments in basic and translational immunology open new exciting perspectives for clinical cell and organ transplantation, including the development of novel immunosuppressive agents, new diagnostic tools and validation of biomarkers for the prediction of rejection as well as the induction of tolerance

    最近基礎和移植免疫學的發展為臨床細胞和器官移植提供了全新的遠景，包括全新免疫抑制藥物的發展、全新的排斥反應的診斷手段、有效的排斥反應預測生物因子、免疫耐受誘導等等。
  8. Although the development of relatively non - toxic immunosuppressive or tolerance - inducing regimens will be required to justify clinical trials using pig organs, recent advances in our understanding of the biology of xenograft rejection and zoonotic infections, and the generation of alpha1, 3 - galactosyltransferase - deficient pigs have moved this approach closer to clinical application

    盡管用豬的器官進行臨床試驗尚有賴于相對無毒的免疫抑制劑或致耐方法的發展，但是我們在異種移植排斥反應及豬源人畜共患病等方面生物學知識的進步，以及1 ， 3半乳糖轉移酶缺陷豬的產生，已經使異種移植離臨床應用更近了一步。
  9. It is well known that tumor necrosis factor a ( tnfa ) can play very different character in defence mechnism of body and pathologic injury, in which it can inhibit or kill tumor cell, and induce inflammation against infection ; on the other hand, tnfa can be as a very important mediator to cause some serious pathologic processes such as septic shock, gvhr and some autoimmune diseases

    腫瘤壞死因子（ tumornecrosisfactor ， tnf ）具有對某些惡性腫瘤的抑制或殺傷作用，也是致內毒素性休克、急性移植物抗宿主病及一些自身免疫病的重要效應因子，因此tnf的改造和tnf拮抗劑的研究受到各國學者的重視。
  10. Although the deelopment of relatiely non - toxic immunosuppressie or tolerance - inducing regimens will be required to justify clinical trials using pig organs, recent adances in our understanding of the biology of xenograft rejection and zoonotic infections, and the generation of alpha1, 3 - galactosyltransferase - deficient pigs hae moed this approach closer to clinical application

    盡管用豬的器官去驗證臨床試驗需要相對無毒的免疫抑制劑或致耐的方法，但隨著近來我們對異種移植排斥生物學及動物傳染病感染的深入理解，以及1 ， 3半乳糖轉移酶缺陷豬的產生，異種移植更接近臨床應用。
  11. In addition to the required courses in emergency and critical care medicine, the institute offers a wide range of courses, including instrumental analysis, epidemiology and biostatistics, general immunology, molecular cell biology, advanced emergency medicine, environmental emergency medicine, infectious disease, traumatology, toxicology, bioethics in critical care, seminar, organ transplantation, medical economics, animal models and technology of medical researches, physiological signal processing, pediatric emergency and critical medicine, geriatric emergency and critical medicine, emergency and critical medicine in obstetrics and gynecology, thesis preparation, symposium, etc

    本所目前的課程除了必修的進階急診醫學及進階重癥醫學外，尚有選修的儀器分析臨床流行病學概論及生物統計免疫學概論細胞分子生物學進階急診醫學環境急癥醫學感染學外傷學毒物學重癥生命倫理學器官移植醫療經濟學醫學研究動物模式與技術生理訊號分析兒童急重癥醫學老人急重癥醫學婦產科急重癥醫學論文撰寫專題討論等。
  12. Topics include ( 1 ) general mechanisms of disease ( inflammation, infection, immune injury, host response to foreign materials, transplantation, genetic disorders and neoplasia ), ( 2 ) pathology of lipids, enzymes and molecular transporters, ( 3 ) pathology of major organ systems, and ( 4 ) review of diagnostic tools from invasive surgical pathology to non - invasive techniques such as optical spectroscopy, functional imaging, and molecular markers of disease

    主題包含（ 1 ）疾病機制通論（發炎，感染，免疫受損，宿主對異物反應，移植，基因異常與癌癥） （ 2 ）脂質、酵素與分子傳送者病理學（ 3 ）主要器官病理學以及（ 4 ）從侵入性手術病理學到非侵入性技術診斷工具的回顧，例如光譜學、功能性影像斷層掃描、和疾病分子標記。
  13. Early immunologic status of patients following hand allotransplantation

    同種異體手移植術後患者的早期免疫學狀態
  14. These one more time proved the multipotential of hscs. and we identified that hscs can differentiate into pancreas in vivo for the first time

    臍血中的造血幹細胞具有獨特的免疫學特性，是一種具有廣泛應用前景的新的幹細胞移植來源。
分享友人
分享到 Line

分享到臉書